HCP5 and neoplasm: Subsequently, we inoculated subcutaneously the treated SGC-7901 cells and results revealed that miR-106b-5p overexpression dramatically facilitated xenograft tumor growth, whereas HCP5 overexpression partly interdicted the effects of enhanced tumorigenicity induced by miR-106b-5p (Fig. 6H-J).